http://www.theatlantic.com/megan-mcardle
Its usually the first thing I go for when I check my RSS feed.
966 karma · joined April 1, 2008
http://www.theatlantic.com/megan-mcardle
Its usually the first thing I go for when I check my RSS feed.
http://see.stanford.edu/materials/aimlcs229/cs229-notes3.pdf
x' = f(x)
as our data, instead of x. It turns out that in lots of machine learning algorithms (notably SVMs), you end up only needing inner products between different data elements. That is, we need to compute x^T y for two data elements x and y. In feature space, we need could compute this by doing f(x)^T f(y). However, it turns out that for certain feature spaces (like polynomials) one can compute the number f(x)^T f(y) quite quickly with out ever explicitly forming the big vectors x' or y'.
But this is definitely a cool visualization of the value of feature spaces!
After reading some of these articles, I decided to give the five fingers a try. At first, my hamstrings and feet were so tired I could hardly walk after running. (You don't realize how many muscles you have in your feet, because you don't use them unless you land on the balls of your feet.)
Now, at about the 1 month point, my hamstrings have strengthened, I still feel a lot of soreness in my feet, but the issues with my knees are completely gone.
Maybe placebo, I know, but I don't mind placebo if it works...
However much that helps.
As for technology, see the comments in the article by economists about the difference between lowering prices based on improved productivity (good) and just lower demand (bad).
Finding the cheapest phone card to use is a good example.
As to "normal" people, I do a lot of numerical computing using python+C. I end up with probably 90% of the code in python, and 10% inner loops in C. That's typically enough that the C code is taking, say, 50% of the time, at which it isn't worth it (for me) to move more python into C, since I could never buy myself more than a factor of 2 speedup.
http://shootout.alioth.debian.org/u32q/benchmark.php?test=al...
Roughly speaking, anything time-critical needs to be done in c.
1) Drug A is 5% effective
2) Placebo is 10% effective
3) No one ever gets the benefits of drug A, since its benefits are masked during trial.
* The drug provides a modest health improvement.
* That health improvement happens to be smaller than the health improvement do to the placebo effect?
I don't know what the typical magnitude of the placebo effect is. If it is substantial, then actually working, actually helpful drugs might be being denied to people. The very mechanisms for the placebo effect he hypothesizes (e.g. people taking care of their health when on a study) certainly seem like they might vary with our culture...
http://en.wikipedia.org/wiki/Nicolas_Bourbaki
Bourbaki's style is not appealing to a lot of people, since it doesn't focus on applications, doesn't use pictures, etc.